Interventional Oncology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Interventional Oncology Market: By Product (Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents(Microspheres, Coated Beads, Microparticles)), Ablation Devices (Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, Other Ablation Devices), Support Devices (Microcatheters, Guidewires), By Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization), By Cancer Type (Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, Other Cancers), By End User (Hospitals, Ambulatory Surgery Centers, Research & Academic Institutes) and Geograpy

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

The interventional Oncology Market size is valued at USD 2.1 billion in 2021. It is expected to reach a value of USD 3.2 billion by 2028, growing at a CAGR of 6.8% during the forecast period from 2022 to 2028. The global market provides a detailed overview of the Interventional Oncology Market, which has been segmented by product, ablation device, support devices, procedure, cancer type, and end user. The interventional oncology market has been segmented into In Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents (Microspheres, Coated Beads, Microparticles). The Embolization Devices segment is likely the most significant and fastest-growing segment in various products. By ablation devices, the interventional oncology market has been segmented into Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Other Ablation Devices. The Radiofrequency (RF) Ablation Devices are expected to account for a significant revenue share during the forecast period. Support devices have segmented the interventional oncology market into Microcatheters, Guidewires. The Microcatheters accounted for a substantial revenue share in 2021. By Procedure, the interventional oncology market has been segmented into Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization. Thermal Tumor Ablation is expected to hold a significant revenue share during the forecast period. The interventional oncology market has been segmented by cancer types: Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, and Other Cancers. The liver cancer segment holds the largest revenue share of the interventional oncology market. Based on the End User, Interventional Oncology is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.

Key development:

In 2021, Boston Scientific (US) launched the TheraSphere Y-90 Glass Microspheres.

Interventional Oncology Market

MARKET SUMMARY
-
6.8%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 6.8%
  • Largest Market– North American
  • Fastest Growing Market– Asia-Pacific

Interventional Oncology Market

  • The Interventional Oncology Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The Interventional Oncology Market is segmented based on product, procedure, cancer type, end user and geography.
Key Players
  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Merit Medical Systems Inc.
  • CR Bard Inc.
Interventional Oncology Market Drivers

According to the World Health Organization (WHO), cancer kills 8.3 million people annually, with 70 % of new cancer cases likely to be recorded in the next 20 years. A rise in cancer patients is expected to be a significant market driver.


North America Got Significant Share

Interventional Oncology Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The interventional oncology market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The interventional oncology market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The interventional oncology market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The interventional oncology market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The interventional oncology market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Interventional Oncology Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Interventional Oncology Market is projected to expand at a CAGR of 6.8% during the forecast period

The major global Interventional Oncology market players are ​​​ Medtronic, AngioDynamics, HealthTronics, Boston Scientific, J&J, BD, Teleflex, Terumo, Cook Medical, and Merit Medical.

North American is the fastest-growing region for Interventional Oncology Market


Report

Table Of Content

1. Executive Summary
2. Global Interventional Oncology Market Introduction
2.1. Global Interventional Oncology Market – Taxonomy
2.2. Global Interventional Oncology Market –Definitions
2.2.1. By Product
2.2.2. By Procedure
2.2.3. By Cancer Type
2.2.4. By End User
2.2.5. By Region
3. Global Interventional Oncology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Interventional Oncology Market Dynamic Factors – Impact Analysis
3.6. Global Interventional Oncology Market – Competition Landscape
4. Global Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Interventional Oncology Market, By Product, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Embolization Devices
5.1.1. Radioembolic Agents
5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Non-Radio embolic Agents
5.1.2.1. Microspheres
5.1.2.1.1.   Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.1.2.   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.1.3.   Market Opportunity Analysis
5.1.2.2. Coated Beads
5.1.2.2.1.   Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.2.2.   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.2.3.   Market Opportunity Analysis
5.1.2.3. Microparticles
5.1.2.3.1.   Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2.3.2.   Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3.3.   Market Opportunity Analysis
5.2. Ablation Devices
5.2.1. Radiofrequency (RF) Ablation Devices
5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.1.3. Market Opportunity Analysis
5.2.2. Microwave Ablation Devices
5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.2.3. Market Opportunity Analysis
5.2.3. Cryoablation Devices
5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3.3. Market Opportunity Analysis
5.2.4. Other Ablation Devices
5.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.4.3. Market Opportunity Analysis
5.3. Support Devices
5.3.1. Microcatheters
5.3.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Guidewires
5.3.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
6. Global Interventional Oncology Market, By Procedure, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Thermal Tumor Ablation
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Non-Thermal Tumor Ablation
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Transcatheter Arterial Chemoembolization
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Transcatheter Arterial Embolization/Bland Embolization
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Interventional Oncology Market, By Cancer Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Liver Cancer
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Lung Cancer
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Bone Metastasis
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Kidney Cancer
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Breast Cancer
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Prostate Cancer
7.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Other Cancers
7.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
8. Global Interventional Oncology Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Ambulatory Surgery Centers
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Research & Academic Institutes
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Interventional Oncology Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Region, 2022-2028
10. North America Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Embolization Devices
10.1.1.1. Radioembolic Agents
10.1.1.2. Non-Radio embolic Agents
10.1.1.2.1. Microspheres
10.1.1.2.2. Coated Beads
10.1.1.2.3. Microparticles
10.1.2. Ablation Devices
10.1.2.1. Radiofrequency (RF) Ablation Devices
10.1.2.2. Microwave Ablation Devices
10.1.2.3. Cryoablation Devices
10.1.2.4. Other Ablation Devices
10.1.3. Support Devices
10.1.3.1. Microcatheters
10.1.3.2. Guidewires
10.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Thermal Tumor Ablation
10.2.2. Non-Thermal Tumor Ablation
10.2.3. Transcatheter Arterial Chemoembolization
10.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
10.2.5. Transcatheter Arterial Embolization/Bland Embolization
10.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Liver Cancer
10.3.2. Lung Cancer
10.3.3. Bone Metastasis
10.3.4. Kidney Cancer
10.3.5. Breast Cancer
10.3.6. Prostate Cancer
10.3.7. Other Cancers
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Research & Academic Institutes
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028
10.7. North America Interventional Oncology Market Dynamics – Trends
11. Europe Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Embolization Devices
11.1.1.1. Radioembolic Agents
11.1.1.2. Non-Radio embolic Agents
11.1.1.2.1. Microspheres
11.1.1.2.2. Coated Beads
11.1.1.2.3. Microparticles
11.1.2. Ablation Devices
11.1.2.1. Radiofrequency (RF) Ablation Devices
11.1.2.2. Microwave Ablation Devices
11.1.2.3. Cryoablation Devices
11.1.2.4. Other Ablation Devices
11.1.3. Support Devices
11.1.3.1. Microcatheters
11.1.3.2. Guidewires
11.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Thermal Tumor Ablation
11.2.2. Non-Thermal Tumor Ablation
11.2.3. Transcatheter Arterial Chemoembolization
11.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
11.2.5. Transcatheter Arterial Embolization/Bland Embolization
11.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Liver Cancer
11.3.2. Lung Cancer
11.3.3. Bone Metastasis
11.3.4. Kidney Cancer
11.3.5. Breast Cancer
11.3.6. Prostate Cancer
11.3.7. Other Cancers
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Research & Academic Institutes
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028
11.7. Europe Interventional Oncology Market Dynamics – Trends
12. Asia-Pacific Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Embolization Devices
12.1.1.1. Radioembolic Agents
12.1.1.2. Non-Radio embolic Agents
12.1.1.2.1. Microspheres
12.1.1.2.2. Coated Beads
12.1.1.2.3. Microparticles
12.1.2. Ablation Devices
12.1.2.1. Radiofrequency (RF) Ablation Devices
12.1.2.2. Microwave Ablation Devices
12.1.2.3. Cryoablation Devices
12.1.2.4. Other Ablation Devices
12.1.3. Support Devices
12.1.3.1. Microcatheters
12.1.3.2. Guidewires
12.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Thermal Tumor Ablation
12.2.2. Non-Thermal Tumor Ablation
12.2.3. Transcatheter Arterial Chemoembolization
12.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
12.2.5. Transcatheter Arterial Embolization/Bland Embolization
12.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Liver Cancer
12.3.2. Lung Cancer
12.3.3. Bone Metastasis
12.3.4. Kidney Cancer
12.3.5. Breast Cancer
12.3.6. Prostate Cancer
12.3.7. Other Cancers
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Research & Academic Institutes
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028
12.7. Asia-Pacific Interventional Oncology Market Dynamics – Trends
13. Latin America Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Embolization Devices
13.1.1.1. Radioembolic Agents
13.1.1.2. Non-Radio embolic Agents
13.1.1.2.1. Microspheres
13.1.1.2.2. Coated Beads
13.1.1.2.3. Microparticles
13.1.2. Ablation Devices
13.1.2.1. Radiofrequency (RF) Ablation Devices
13.1.2.2. Microwave Ablation Devices
13.1.2.3. Cryoablation Devices
13.1.2.4. Other Ablation Devices
13.1.3. Support Devices
13.1.3.1. Microcatheters
13.1.3.2. Guidewires
13.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Thermal Tumor Ablation
13.2.2. Non-Thermal Tumor Ablation
13.2.3. Transcatheter Arterial Chemoembolization
13.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
13.2.5. Transcatheter Arterial Embolization/Bland Embolization
13.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Liver Cancer
13.3.2. Lung Cancer
13.3.3. Bone Metastasis
13.3.4. Kidney Cancer
13.3.5. Breast Cancer
13.3.6. Prostate Cancer
13.3.7. Other Cancers
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Research & Academic Institutes
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028
13.7. Latin America Interventional Oncology Market Dynamics – Trends
14. Middle East and Africa Interventional Oncology Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Embolization Devices
14.1.1.1. Radioembolic Agents
14.1.1.2. Non-Radio embolic Agents
14.1.1.2.1. Microspheres
14.1.1.2.2. Coated Beads
14.1.1.2.3. Microparticles
14.1.2. Ablation Devices
14.1.2.1. Radiofrequency (RF) Ablation Devices
14.1.2.2. Microwave Ablation Devices
14.1.2.3. Cryoablation Devices
14.1.2.4. Other Ablation Devices
14.1.3. Support Devices
14.1.3.1. Microcatheters
14.1.3.2. Guidewires
14.2. Procedure Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Thermal Tumor Ablation
14.2.2. Non-Thermal Tumor Ablation
14.2.3. Transcatheter Arterial Chemoembolization
14.2.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
14.2.5. Transcatheter Arterial Embolization/Bland Embolization
14.3. Cancer Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Liver Cancer
14.3.2. Lung Cancer
14.3.3. Bone Metastasis
14.3.4. Kidney Cancer
14.3.5. Breast Cancer
14.3.6. Prostate Cancer
14.3.7. Other Cancers
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Research & Academic Institutes
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Interventional Oncology Market – Opportunity Analysis Index, By Product, Procedure, Cancer Type, End User, and Country, 2022-2028
14.7. MEA Interventional Oncology Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Boston Scientific Corporation
15.2.2. Medtronic PLC
15.2.3. Terumo Corporation
15.2.4. Merit Medical Systems Inc.
15.2.5. CR Bard Inc.
15.2.6. Profound Medical Corp.
15.2.7. AngioDynamics Inc.
15.2.8. Cook Medical LLC
15.2.9. HealthTronics Inc.
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Boston Scientific Corporation
  • Medtronic PLC
  • Terumo Corporation
  • Merit Medical Systems Inc.
  • CR Bard Inc.
  • Profound Medical Corp.
  • AngioDynamics Inc.
  • Cook Medical LLC
  • HealthTronics Inc.

Description

The interventional Oncology Market size is valued at USD 2.1 billion in 2021. It is expected to reach a value of USD 3.2 billion by 2028, growing at a CAGR of 6.8% during the forecast period from 2022 to 2028. The global market provides a detailed overview of the Interventional Oncology Market, which has been segmented by product, ablation device, support devices, procedure, cancer type, and end user. The interventional oncology market has been segmented into In Embolization Devices (Radioembolic Agents, Non-Radio embolic Agents (Microspheres, Coated Beads, Microparticles). The Embolization Devices segment is likely the most significant and fastest-growing segment in various products. By ablation devices, the interventional oncology market has been segmented into Radiofrequency (RF) Ablation Devices, Microwave Ablation Devices, Cryoablation Devices, and Other Ablation Devices. The Radiofrequency (RF) Ablation Devices are expected to account for a significant revenue share during the forecast period. Support devices have segmented the interventional oncology market into Microcatheters, Guidewires. The Microcatheters accounted for a substantial revenue share in 2021. By Procedure, the interventional oncology market has been segmented into Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy, Transcatheter Arterial Embolization/Bland Embolization. Thermal Tumor Ablation is expected to hold a significant revenue share during the forecast period. The interventional oncology market has been segmented by cancer types: Liver Cancer, Lung Cancer, Bone Metastasis, Kidney Cancer, Breast Cancer, Prostate Cancer, and Other Cancers. The liver cancer segment holds the largest revenue share of the interventional oncology market. Based on the End User, Interventional Oncology is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.

Key development:

In 2021, Boston Scientific (US) launched the TheraSphere Y-90 Glass Microspheres.

Reviews

There are no reviews yet.

Be the first to review “Interventional Oncology Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX